Search alternatives:
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
0 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
0 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
56781
Image_4_Epidemic Trends in High Tuberculosis Burden Countries During the Last Three Decades and Feasibility of Achieving the Global Targets at the Country Level.TIF
Published 2022“…</p>Results<p>The incidence and mortality decreased in most of the HBCs. The AAPCs of incidence ranged between −4.0 (Indonesia) and −0.2% (DR Congo) (all p < 0.05). …”
-
56782
Image_1_Epidemic Trends in High Tuberculosis Burden Countries During the Last Three Decades and Feasibility of Achieving the Global Targets at the Country Level.TIF
Published 2022“…</p>Results<p>The incidence and mortality decreased in most of the HBCs. The AAPCs of incidence ranged between −4.0 (Indonesia) and −0.2% (DR Congo) (all p < 0.05). …”
-
56783
Image_3_Epidemic Trends in High Tuberculosis Burden Countries During the Last Three Decades and Feasibility of Achieving the Global Targets at the Country Level.TIF
Published 2022“…</p>Results<p>The incidence and mortality decreased in most of the HBCs. The AAPCs of incidence ranged between −4.0 (Indonesia) and −0.2% (DR Congo) (all p < 0.05). …”
-
56784
Image_2_Epidemic Trends in High Tuberculosis Burden Countries During the Last Three Decades and Feasibility of Achieving the Global Targets at the Country Level.TIF
Published 2022“…</p>Results<p>The incidence and mortality decreased in most of the HBCs. The AAPCs of incidence ranged between −4.0 (Indonesia) and −0.2% (DR Congo) (all p < 0.05). …”
-
56785
HLA high-resolution typing by next-generation sequencing in Pandemrix-induced narcolepsy
Published 2019“…Indeed, this extended haplotype was found in 30/31 patients (96.8%) and 178/636 GP (28.0%). In total, 15 alleles, four extended haplotypes, and six genotypes were found to be increased or decreased in frequency among NT1 patients compared to GP. …”
-
56786
Optimizing replay intensity and resolution in aberration-compensated off-axis holograms by ambient humidity control
Published 2019“…Sheridan: "Improvement of Holographic Recording Material Using Aerosol Sealant" <em>Journal of Optics A : Pure and Applied Optics</em> <strong>3</strong> pp. 20-25 (2001).</p><p></p><p><u><br></u></p><u>References</u><p></p><p>1. …”
-
56787
Datasheet3_Catheter ablation vs. drug therapy in the treatment of atrial fibrillation patients with heart failure: An update meta-analysis for randomized controlled trials.docx
Published 2023“…According to the meta-analysis, catheter ablation significantly reduced all-cause mortality compared with drug therapy [9.2% vs. 14.1%, OR: 0.62, (95% CI: 0.47–0.82), P = 0.0007, I<sup>2</sup><sup> </sup>= 0%], improved LVEF [MD: 5.65%, (95% CI: 3.32–7.98), P < 0.00001, I<sup>2</sup><sup> </sup>= 86%], reduced AF recurrence [41.6% vs. 61.9%, OR: 0.23, (95% CI: 0.11–0.48), P < 0.0001, I<sup>2</sup><sup> </sup>= 82%], decreased the MLHFQ score [MD: −6.38, (95% CI: −11.09 to −1.67), P = 0.008, I<sup>2 </sup>= 64%] and increased 6MWD [MD: 17.55, (95% CI: 15.77–19.33), P < 0.0001, I<sup>2</sup><sup> </sup>= 37%]. …”
-
56788
Table1_Catheter ablation vs. drug therapy in the treatment of atrial fibrillation patients with heart failure: An update meta-analysis for randomized controlled trials.docx
Published 2023“…According to the meta-analysis, catheter ablation significantly reduced all-cause mortality compared with drug therapy [9.2% vs. 14.1%, OR: 0.62, (95% CI: 0.47–0.82), P = 0.0007, I<sup>2</sup><sup> </sup>= 0%], improved LVEF [MD: 5.65%, (95% CI: 3.32–7.98), P < 0.00001, I<sup>2</sup><sup> </sup>= 86%], reduced AF recurrence [41.6% vs. 61.9%, OR: 0.23, (95% CI: 0.11–0.48), P < 0.0001, I<sup>2</sup><sup> </sup>= 82%], decreased the MLHFQ score [MD: −6.38, (95% CI: −11.09 to −1.67), P = 0.008, I<sup>2 </sup>= 64%] and increased 6MWD [MD: 17.55, (95% CI: 15.77–19.33), P < 0.0001, I<sup>2</sup><sup> </sup>= 37%]. …”
-
56789
Datasheet2_Catheter ablation vs. drug therapy in the treatment of atrial fibrillation patients with heart failure: An update meta-analysis for randomized controlled trials.docx
Published 2023“…According to the meta-analysis, catheter ablation significantly reduced all-cause mortality compared with drug therapy [9.2% vs. 14.1%, OR: 0.62, (95% CI: 0.47–0.82), P = 0.0007, I<sup>2</sup><sup> </sup>= 0%], improved LVEF [MD: 5.65%, (95% CI: 3.32–7.98), P < 0.00001, I<sup>2</sup><sup> </sup>= 86%], reduced AF recurrence [41.6% vs. 61.9%, OR: 0.23, (95% CI: 0.11–0.48), P < 0.0001, I<sup>2</sup><sup> </sup>= 82%], decreased the MLHFQ score [MD: −6.38, (95% CI: −11.09 to −1.67), P = 0.008, I<sup>2 </sup>= 64%] and increased 6MWD [MD: 17.55, (95% CI: 15.77–19.33), P < 0.0001, I<sup>2</sup><sup> </sup>= 37%]. …”
-
56790
Datasheet4_Catheter ablation vs. drug therapy in the treatment of atrial fibrillation patients with heart failure: An update meta-analysis for randomized controlled trials.docx
Published 2023“…According to the meta-analysis, catheter ablation significantly reduced all-cause mortality compared with drug therapy [9.2% vs. 14.1%, OR: 0.62, (95% CI: 0.47–0.82), P = 0.0007, I<sup>2</sup><sup> </sup>= 0%], improved LVEF [MD: 5.65%, (95% CI: 3.32–7.98), P < 0.00001, I<sup>2</sup><sup> </sup>= 86%], reduced AF recurrence [41.6% vs. 61.9%, OR: 0.23, (95% CI: 0.11–0.48), P < 0.0001, I<sup>2</sup><sup> </sup>= 82%], decreased the MLHFQ score [MD: −6.38, (95% CI: −11.09 to −1.67), P = 0.008, I<sup>2 </sup>= 64%] and increased 6MWD [MD: 17.55, (95% CI: 15.77–19.33), P < 0.0001, I<sup>2</sup><sup> </sup>= 37%]. …”
-
56791
Datasheet1_Catheter ablation vs. drug therapy in the treatment of atrial fibrillation patients with heart failure: An update meta-analysis for randomized controlled trials.docx
Published 2023“…According to the meta-analysis, catheter ablation significantly reduced all-cause mortality compared with drug therapy [9.2% vs. 14.1%, OR: 0.62, (95% CI: 0.47–0.82), P = 0.0007, I<sup>2</sup><sup> </sup>= 0%], improved LVEF [MD: 5.65%, (95% CI: 3.32–7.98), P < 0.00001, I<sup>2</sup><sup> </sup>= 86%], reduced AF recurrence [41.6% vs. 61.9%, OR: 0.23, (95% CI: 0.11–0.48), P < 0.0001, I<sup>2</sup><sup> </sup>= 82%], decreased the MLHFQ score [MD: −6.38, (95% CI: −11.09 to −1.67), P = 0.008, I<sup>2 </sup>= 64%] and increased 6MWD [MD: 17.55, (95% CI: 15.77–19.33), P < 0.0001, I<sup>2</sup><sup> </sup>= 37%]. …”
-
56792
-
56793
Dataset: Increased Organic Carbon Burial in Northern Florida Mangrove-Salt Marsh Transition Zones
Published 2021“…Higher amino acid concentrations in mangrove soils relative to mangrove biomass (1.8-2.3 mmol gC<sup>-1</sup> vs. 0.2-0.9 mmol gC<sup>-1</sup>) and lower C/N indicated these mangrove sites receive higher algal inputs than the transition and salt marsh sites, attributed to greater tidal inundation in the mangrove sites given their position near the shoreline. …”
-
56794
Dataset used in the manuscript.
Published 2024“…Caregivers had more severe symptoms of depression and/or anxiety if they experienced greater changes in living situations or decreases in physical activity (CESD-20: β = 3.35, 95% CI [1.00, 5.70], p = .01), food insecurity (HSCL-25: β = 3.25, 95% CI [0.41, 6.10], p = .03, CESD-25: β = 3.09, 95% CI [0.79, 5.39], p = .01), and domestic violence (HSCL-25: β = 3.82, 95% CI [0.94, 6.70], p = .01) during COVID-19. …”
-
56795
LRIG1 and CDK6 expression in the lateral ventricular wall cells
Published 2025“…</p><p dir="ltr">Culture medium:</p><p dir="ltr">DMEM/F-12 + GlutaMAX (GIbco)</p><p dir="ltr">20 mM HEPES (Gibco)</p><p dir="ltr">1x B27 minus Vitamin A (Gibco)</p><p dir="ltr">20 ng/ml mouse FGF2 (R & D, Peprotech, Gold Bio)</p><p dir="ltr">20 ng/ml mouse EGF (same sources)</p><p dir="ltr">2 µg/ml heparin (Sigma, tissue culture grade)</p><p dir="ltr">1x Primocin (InvivoGen, especially good for fungus)</p><p dir="ltr">Others often supplement with N2, insulin-transferrin-selenium, chick embryo extract, etc.…”
-
56796
-
56797
Results of <i>in silico</i> perturbation experiments.
Published 2011“…In (<b>A</b>) and (<b>B</b>), well-formed smaller <b>somites</b> (top of each panel) require decreased <b>cell</b> motility (for <b>PSM cells</b>, <i>λ</i><sub>surf</sub> = 20 and <i>D</i><sub>cell</sub> = 0.945 µm<sup>2</sup>/min in (<b>A</b>); <i>λ</i><sub>surf</sub> = 25 in (<b>B</b>)); larger <b>somites</b> form for reference motility parameters. …”
-
56798
Harmonic Shears for Skeletonized Internal Thoracic Arteries and Great Saphenous Vein Harvesting
Published 2018“…<i><a href="https://doi.org/10.1016/j.athoracsur.2009.09.061">Ann Thorac Surg. 2010;89(2):403-408</a></i>.…”
-
56799
Hypokalemia, Its Contributing Factors and Renal Outcomes in Patients with Chronic Kidney Disease
Published 2013“…</p><p>Results</p><p>The mean age was 62.4 years, mean sK level was 4.2±0.5 mEq/L and average eGFR was 40.6 ml/min per 1.73 m<sup>2</sup>. …”
-
56800
YorkU.forest.Oct25-2016.csv
Published 2016“…The bowls were left there for 30 minutes from 3:20 to 3:50. After 30 minutes have elapsed, the number of insects in each bowl was counted.…”